Author Topic: NF2 clinical trial at MGH  (Read 8931 times)

Susan A

  • Full Member
  • ***
  • Posts: 110
NF2 clinical trial at MGH
« on: November 11, 2016, 01:53:59 pm »
Dr Plotkin at Mass General Hospital is starting a new Phase 2 clinical trial for people with NF2. The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.
2011 8 x 7 mm AN, & 20 x 22 mm M found, both on the left. Mosaic NF2 diagnosed. Some hearing loss
2014 hearing 30% on left, now using hearing aid (HA)
2015 Now have CROS HA - no longer hear enough for HA to be useful in AN ear
2016 Use an FM system on occasion at work to supplement HA


  • Full Member
  • ***
  • Posts: 232
20 x19x14mm AN diagnosed Feb 2019. Cyberknife .
Mri Oct 2019 showed shrinking to: 18x17x13 mm.
Mri Oct 2020 - no cystic components visible now. Slight shrinking, stable.
MRI 2021 stable no change
MRI 2022 stable no change.